HealthDay on MSN2h
AHA: GLP-1 RA, SGLT-2i Use Can Lower Risk for MI, Recurrent Stroke in Stroke SurvivorsFor patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor ...
University of Wisconsin–Madison researchers targeting a group of hereditary neurodegenerative diseases have found success ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback